The current marketplace is in extreme difficulty for everyone and especially for the biotechnology sector. Most investors fail to understand that the products in this sector take long time frames to commercialization and that there is no quick solution as the regulatory procedures dictate and drive the requirements for all companies. BPO progress with their natural insecticide Qcide has been very positive as it continues to clear the field evaluation hurdles. Only when the company is able to sign and announce a commercialization agreement with their collaborators will we all see results of BPO efforts. Please be assured that BPO commitment to improving your investment is their total priority.
BPO Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
